Lotus Eye Hospital and Institute Limited has informed the Exchange regarding Board meeting held on August 12, 2025.
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lotus Eye Hospital and Institute Limited has informed the exchanges about its board meeting held on August 12, 2025, where it approved the unaudited standalone financial results for the quarter ended June 30, 2025. Revenue from operations stood at Rs. 1,351.69 lakhs, up about 2.4% from Rs. 1,319.68 lakhs in the same quarter last year. Net profit came in at Rs. 54.48 lakhs, down roughly 12.6% year-on-year from Rs. 62.34 lakhs in Q1 FY25, while basic and diluted EPS stood at Rs. 0.26 (vs Rs. 0.30 last year). On a sequential basis, revenue grew about 17% and net profit more than doubled compared to Q4 FY25 (Rs. 25.23 lakhs). The results have been subject to a limited review by statutory auditors Anbarasu & Jalapathi, Chartered Accountants. For the full year ended March 31, 2025, total income was Rs. 5,086.38 lakhs and net profit was Rs. 73.93 lakhs with an EPS of Rs. 0.36.
Marginal YoY revenue growth combined with a decline in profit indicates some margin pressure, but the sharp sequential recovery from Q4 FY25 is a positive signal. Overall, the numbers are mixed and are unlikely to trigger a major stock price move on their own.